Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Further correction: Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy
Vaibhav
Khare
ab,
Wejdan Al.
Sakarchi
a,
Prem N.
Gupta
b,
Anthony D. M.
Curtis
a and
Clare
Hoskins
*a
aInstitute of Science and Technology in Medicine, Keele University, Keele, Staffordshire, ST55BJ, UK. E-mail: c.hoskins@keele.ac.uk
bFormulation and Drug Delivery Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, India 180001
First published on 20th March 2017
Abstract
Further correction for ‘Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy’ by Vaibhav Khare et al., RSC Adv., 2016, 6, 60126–60137.
The structures shown in Fig. 1 of the previous correction to the original manuscript were incomplete. The corrected Fig. 1 is shown below.
 | ||
| Fig. 1 A schematic representation of the reaction involved in the synthesis of tocopherol polyethylene glycol succinate 1000 (TPGS)–gemcitabine prodrug. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2017 |